Literature DB >> 16755497

Increase in mitochondrial DNA quantity and impairment of oxidative phosphorylation in bovine fibroblast cells treated with ethidium bromide for 15 passages in culture.

Marcos Roberto Chiaratti1, Flávio Vieira Meirelles.   

Abstract

Bovine fetal fibroblast cells were treated with ethidium bromide at a low concentration for 15 passages in culture to determine its effect on mitochondrial DNA copy number and on cell metabolism. Mitochondrial membrane potential and lactate production were estimated in order to characterize cell metabolism. In addition, mitochondrial DNA ND5 in proportion to a nuclear gene (luteinizing hormone receptor) was determined at the 1st, 2nd, 3rd, 10th, and 15th passages using semi-quantitative PCR amplification. Treated cells showed a lower mitochondrial membrane potential and higher levels of lactate production compared with control cells. However, the mitochondrial DNA/nuclear DNA ratio was higher in treated cells compared with control cells at the 10th and 15th passages. This ratio changed between the 3rd and 10th passages. Despite a clear impairment in mitochondrial function, ethidium bromide treatment did not lead to mitochondrial DNA depletion. It is possible that in response to a lower synthesis of ATP, due to an impairment in oxidative phosphorylation, treated cells develop a mechanism to resist the ethidium bromide effect on mtDNA replication, resulting in an increase in mitochondrial DNA copy number.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16755497

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  5 in total

1.  Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain.

Authors:  Claudia R Oliva; Susan E Nozell; Anne Diers; Samuel G McClugage; Jann N Sarkaria; James M Markert; Victor M Darley-Usmar; Shannon M Bailey; G Yancey Gillespie; Aimee Landar; Corinne E Griguer
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

2.  Possible Mitochondria-Associated Enzymatic Role in Non-Hodgkin Lymphoma Residual Disease.

Authors:  Ian Kusao; David Troelstrup; Bruce Shiramizu
Journal:  Cancer Growth Metastasis       Date:  2008-11-24

3.  Chemotoxicity recovery of mitochondria in non-Hodgkin lymphoma resulting in minimal residual disease.

Authors:  Ian Kusao; Melissa Agsalda; David Troelstrup; Nicolas Villanueva; Bruce Shiramizu
Journal:  Pediatr Blood Cancer       Date:  2008-08       Impact factor: 3.167

4.  Edition of TFAM gene by CRISPR/Cas9 technology in bovine model.

Authors:  Vanessa Cristina de Oliveira; Gabriel Sassarão Alves Moreira; Fabiana Fernandes Bressan; Clésio Gomes Mariano Junior; Kelly Cristine Santos Roballo; Marine Charpentier; Jean-Paul Concordet; Flávio Vieira Meirelles; Carlos Eduardo Ambrósio
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

5.  Bradykinin Protects Human Endothelial Progenitor Cells from High-Glucose-Induced Senescence through B2 Receptor-Mediated Activation of the Akt/eNOS Signalling Pathway.

Authors:  Yuehuan Wu; Cong Fu; Bing Li; Chang Liu; Zhi He; Xing-Er Li; Ailing Wang; Genshan Ma; Yuyu Yao
Journal:  J Diabetes Res       Date:  2021-09-11       Impact factor: 4.011

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.